| Indicator |
Aldrete score |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Post Anaesthetic Discharge Scoring System |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
An In-House score |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Anxiety |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Pain |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Postoperative Nausea and Vomiting(PONV) |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Concomitant medication |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Vital signs |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Pain intensity |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Consumption of analgesics |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Sedative drugs dose |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Bispectral index(BIS) |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Indicator |
Shivering |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Acupoint |
Shuigou|GV26 |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Acupoint |
Danzhong|CV17 |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Acupoint |
Hegu|LI4 |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Acupoint |
Shenmen|HT7 |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Acupoint |
Taichong|LR3 |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Acupoint |
Zusanli|ST36 |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Acupoint |
Neiguan|PC6 |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Shuigou|GV26 |
middle body line |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Shuigou|GV26 |
bilaterally |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Danzhong|CV17 |
middle body line |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Danzhong|CV17 |
bilaterally |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Hegu|LI4 |
middle body line |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Hegu|LI4 |
bilaterally |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Shenmen|HT7 |
middle body line |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Shenmen|HT7 |
bilaterally |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Taichong|LR3 |
middle body line |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Taichong|LR3 |
bilaterally |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Zusanli|ST36 |
middle body line |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Zusanli|ST36 |
bilaterally |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Neiguan|PC6 |
middle body line |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Neiguan|PC6 |
bilaterally |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Stimulation_Method |
MS |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| MS |
0.2×1.5 mm |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| MS |
Seirin Co. Ltd, Shizuoka City, Japan |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Auxiliary_Medication |
Metamizol |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Auxiliary_Medication |
Dexamethasone |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Auxiliary_Medication |
Ranitidine |
75 |
Laparoscopic Surgery to Uterus or Ovaries |
| Auxiliary_Medication |
Piritramide |
75 |
Laparoscopic Surgery to Uterus or Ovaries |